Intrapartum Monitoring Devices Market Segmentation:
End user Segment Analysis
The hospital sub-segment dominates the segment and is expected to hold the segment share of 38.6% by 2034. The segment is driven by the role in managing complex deliveries, advanced intrapartum care, and emergency obstetrics. The public sector is actively spending on the maternal health programs and promoting equipment purchase among tertiary care institutions. Centers for Medicare & Medicaid Services has stated that the performance-based incentives under maternal health and ongoing reimbursement together directly support the adoption of the devices in U.S. hospitals. The need for hospital-based devices is further fueled by WHO's global maternal health programs, which encourage clinical capacity-building in public institutions for continuous monitoring throughout labor.
Product Type Segment Analysis
The electronic fetal monitors (EFM) hold the largest share in the segment and are expected to have a market share of 33.7% by 2034. The electronic fetal monitors sub-segment is the backbone of intrapartum monitoring, with 85.6% of women laboring in the U.S. being monitored using EFM. The market is driven by regulatory approval, incorporation in standard obstetric protocols, and clinical reliability. Further, the U.S. FDA data on the device clearance highlights a steady rise in new gen EFMs, with the latest features, such as automated heart rate variability analysis and telemetry, gaining attention in private and public hospitals.
Our in-depth analysis of the global intrapartum monitoring devices market includes the following segments:
|
Segment |
Subsegments |
|
Product Type |
|
|
Technology |
|
|
End user |
|
